Congress Can't Wait—Reform Pharmacy Benefit Managers and Deliver Lower-Cost Drugs for Patients | Opinion
As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...
Only an act of Congress can stop pharmacy monopolies, Sen. Lankford says
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
penncapital-star2dOpinion
Inflated drug costs hurt Pennsylvanians
The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...
Yahoo5d
Trump has promised to ‘knock out’ pharmacy benefit managers. How the drug middlemen became a $557 billion industry that its customers love to hate
In late December, President-elect Donald Trump put pharmacy benefit managers ... Warren and activist regulators at Joe Biden’s Federal Trade Commission, which dropped a report just days before ...
JD Supra5d
FTC Issues PBM Report Signaling Consolidation Is Impacting Pharmaceutical Prices
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...
‘Knock out the middlemen’: A campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Yahoo Finance6d
The Cigna Group (CI)
Major pharmacy-benefit managers generated $7.3 billion in markups on specialty drugs from pharmacies they are affiliated with, the FTC said in a new report. The markups helped the pharmacy-benefit ...
JD Supra1d
A Year-End Report for Healthcare Antitrust and What to Expect Later in 2025
As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust ...